miRNAs and Melanoma: How Are They Connected?

Adriana Taveira da Cruz1, Miriam Galvonas Jasiulionis

  • 1Microbiology, Immunology and Parasitology Department, Universidade Federal de São Paulo, 04039-032 São Paulo, SP, Brazil.

Insights

MicroRNAs (miRNAs) regulate gene expression and are crucial in biological responses. This review explores their role in melanoma, focusing on epigenetic regulation for potential diagnosis and therapy.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are non-coding RNAs regulating gene posttranscriptional processes, impacting cell proliferation, apoptosis, and stress responses.
  • Dysregulation of miRNAs is implicated in cancer development, with altered miRNA function potentially driving tumor progression.
  • Melanoma, a complex skin cancer with a high mortality rate for metastatic forms, exhibits disrupted molecular pathways where miRNAs likely play a key role.

Purpose of the Study:

  • To review recent findings on microRNAs in melanoma.
  • To discuss epigenetic processes influencing miRNA expression in melanoma.
  • To explore the potential of miRNAs in melanoma diagnosis and therapy.

Main Methods:

  • Literature review of current research on miRNAs and melanoma.
  • Analysis of epigenetic mechanisms affecting miRNA expression.
  • Discussion of diagnostic and therapeutic applications of miRNAs in melanoma.

Main Results:

  • miRNAs are critical regulators of gene expression and are involved in numerous cellular pathways.
  • Altered miRNA expression and function are significantly linked to melanoma development and progression.
  • Epigenetic modifications are key factors influencing miRNA dysregulation in melanoma.

Conclusions:

  • Understanding miRNA regulation and epigenetic alterations in melanoma is crucial for developing novel treatment strategies.
  • miRNAs hold promise as biomarkers for melanoma diagnosis and as therapeutic targets.
  • Further research into miRNA-epigenetic interactions could revolutionize melanoma management.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...